baber/WOPTO huggingface dataset:
Patent DE-69121236-T2 (DE)
Inventor: KAGAWA SEIJI
IPC: B26F1/28
Filed: 1991-05-23
Granted: 1997-01-09
Abstract: A porous film manufacturing apparatus is disclosed, which can continuously and uniformly form a large number of uniform through pores or blind pores, each having a size arbitrarily selected in the range of sub- mu m to several tens  mu m, in an elongated film (36) made of various types of materials, such as polymeric materials and metals, at a high density (e.g., 5,000 to 200,000 per cm<2>), without almost any deterioration in essential characteristics of the film materials. The manufacturing apparatus includes a feed means for feeding an elongated film (36), a perforating unit (20) including a first rotatable roll (6) having a surface on which a large number of particles (7), each having acute corner portions and a Mohs hardness value of not less than 5, are deposited, and a second roll (16) which is rotatable in a direction reverse to a rotating direction of the first roll (6), the first and second rolls (6, 16) being arranged to oppose each other and to cause the elongated film (36) to pass therebetween, one of the rolls (6, 16) being stationary, and the other roll (16) being movable in a direction to oppose the one roll (6), and a pressure control means (35), arranged near two end portions of the movable roll (16) of the unit (20), for controlling a pressure applied from each of the rolls (6, 16) to the film (36). <IMAGE>
Patent DE-69132914-T2 (DE)
Inventor: BARTLETT PAUL A
IPC: A61K47/48
Filed: 1991-06-14
Granted: 2002-09-19
Abstract: Peptoids are provided which are polymers comprised of monomer units wherein the monomer units include at least some substitute amino acids and may include conventional amino acids. The peptoids can be synthesized in large numbers so as to provide libraries of peptoids which can be screened in order to isolate peptoids of desired biological activity. Certain peptoids are designed to mimic as closely as possible the activity of known proteins. Other peptoids are designed so as to have greater or lesser activity than known proteins and may be designed so as to block known receptor sites and/or elicit a desired immunogenic response and thereby act as vaccines. A range of different amino acid substitutes are disclosed, as are their methods of synthesis and methods of using such amino acid substitutes in the synthesis of peptoids and peptoid libraries. Methods of screening the libraries in order to obtain desired peptoids of a particular biological activity are also disclosed. The peptoids are preferably linked to a pharmaceutically active drug forming a conjugate with increased binding affinity to a particular biological receptor site.
Patent DE-69201512-T2 (DE)
Inventor: REID LEONARD F
IPC: B21D39/06
Filed: 1992-05-04
Granted: 1995-07-13
Abstract: A tubular bushing (68) is positioned into an opening (92) in a member (88). An axially split expansion sleeve (66) is placed onto a small diameter portion (54) of an extended mandrel (40). The mandrel (10) includes an increasing diameter portion (56) and a maximum diameter end portion (58) endwise from the small diameter portion (54). The maximum diameter portion (58) is sized to fit through the tubular bushing (68). The expansion sleeve (66), while on the small diameter portion (54) of the mandrel (10) can also fit through the bushing (68). The sleeve (66) is placed on the small diameter portion (54) of the mandrel (10) with its inner end (76) against the end (78) of a sleeve positioner (40). A tubular nosepiece (16) surrounds the sleeve positioner (40), and extend axially beyond the end surface (78). The mandrel (10) is inserted through the bushing (68) while the bushing (68) is within opening (92). The mandrel (10) is moved to place the sleeve (66) within the bushing (68), and an end surface (41) of the nosepiece (16) against a surface portion (84) of the workpiece (88). At the same time, the end surface (43) of a nosepiece extension (39) is positioned against an end surface (82) of the bushing (68). The mandrel (10) is then pulled through the sleeve (66). Movement of the increasing diameter portion (56) and the maximum diameter portion (58) through the sleeve (66) imposes a radially outwardly directed force on the sleeve (66), causing the sleeve (66) to expand. The expanding sleeve (66) exerts a radially outwardly directed force on the bushing (68). In response, the bushing (68) is expanded radially into a secure interference fit within the opening (92) in the workpiece (88). <IMAGE>
Patent DE-69207584-T2 (DE)
Inventor: DUDZIK HENRYK
IPC: B65D41/04
Filed: 1992-02-21
Granted: 1996-06-27
Abstract: PCT No. PCT/GB92/00315 Sec. 371 Date Oct. 12, 1993 Sec. 102(e) Date Oct. 12, 1993 PCT Filed Feb. 21, 1992 PCT Pub. No. WO92/15495 PCT Pub. Date Sep. 17, 1992.A cap (20) is provided with a sealing pad (31) made of good barrier material for the contents of a bottle on which the cap is engaged. The pad has annular projections (33, 34) which sealingly engage with the inner wall (13) and the rim (15) respectively of a mouth of the bottle. The pad is retained in the cap by a retaining ring (30) projecting radially inwardly from the skirt (22) of the cap and this ring engages the outer wall (14) of the mouth to provide a third seal between the cap and the bottle.
Patent DE-69214230-T2 (DE)
Inventor: BORSODI ANNA
IPC: A61K31/485
Filed: 1992-02-03
Granted: 1997-02-20
Abstract: A biologically active preparation for human or veterinary use for the selective blockade of opioid binding sites of the brain responsible for respiratory depression containing in a biologically active quantity the codeinone derivative of general formula (I) or its salt R1 means amino-, hydroxyl-, -NH-phenyl or -NH-CO-NH2groups, R2 means a hydrogen atom or a hydroxyl group. The invention also covers a process for selective blocking the opioid binding sites of the brain responsible for respiratory depression by administering to a patient in need of an analgetic a preparation containing a codeinone derivative of general formula (I) or its salt preferably three times per day in doses of 2.5-5 mg. A preferred feature of the inventions is an analgetic composition containing a codeinone derivative of general formula (I) and in a mass ratio of 1:2-3 morphine of the formula (IV) or an other, biologically equipotent agonist type opiate or opioid compound and optionally inert, pharmaceutically acceptable accompanying materials.
Patent DE-69219488-T2 (DE)
Inventor: AUDOUX JEAN-NOEL
IPC: G06K19/077
Filed: 1992-01-03
Granted: 1997-10-30
Abstract: The method according to the text of the application consists in providing the body (1) of the card with a cavity (2) and with a conduction area (5) situated partly in the cavity (2) and partly outside it; in inserting an fixing the integrated circuit (3) in the cavity (2) in such a way that its solder pads (4, 4a) are turned outwards; in forming by deposition a first layer of dielectric varnish (6) on the integrated circuit (3), with the exception of the solder pads (4, 4a) of the latter, and on part of the body (1) which surrounds the cavity (2), with the exception of an area (7) situated immediately in line with the conduction area (5); in forming read/write contacts (9, 9a) as well as the conductors (8) linking these latter to the respective solder pads (4, 4a) of the integrated circuit (3) by deposition of a conducting ink on the said solder pads (4, 4a), on the first layer of varnish (6), and on the part which is not coated with varnish of the conduction area (5) so that it is linked to one of the conductors; and in forming by deposition a second layer of dielectric varnish (10) on the parts of the ink deposit which do not constitute the read/write contacts (9, 9a). <IMAGE>
Patent DE-69230013-T2 (DE)
Inventor: DUGGAN MARK E
IPC: A61K31/44
Filed: 1992-05-07
Granted: 2000-04-27
Abstract: Fibrinogen receptor antagonists of the formula: <CHEM> are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
Patent DE-69230104-T2 (DE)
Inventor: KLEMKE R ERICH
IPC: C07J75/00
Filed: 1992-07-21
Granted: 2000-08-24
Abstract: Steroidal and non-steroidal glycosides and a method of producing them are provided, wherein aglycon compounds are glycosylated with tri-O-acyl glucal using molecular or ionized halogen as reaction catalyst. The aglycon, which may be a non-steroid or a steroid having a reactive functional group (e.g., -OH, -SH, -COOH, -NH2, -NHR1) such as a cholesterol, is glycosylated, wherein the glycosylation is performed in a single step. For example, a steryl pyranoside is oxidized to the corresponding 7-ketosteryl di-O-acyl-pyranoside, which is selectively reduced to provide the corresponding 7-beta-hydroxysteryl 2,3-dideoxy-alpha-D-erythro-hex-2-enopyranoside. These steroidal and non-steroidal glycosides possess valuable pharmacological properties. In particular, the cholesterol glycoside exhibits a selective cell-destructive activity on malignant cell, in vivo, and is substantially free of side effects on normal cells. The glycosides possess useful pharmacological properties which are the same as their respective unglycosylated aglycons, which properties include a drive-enhancing (stimulating) activity and an anti-inflammatory (immunosuppressive or immunoregulatory) activity.
Patent DE-69304172-T2 (DE)
Inventor: N GUYEN QUANG LAN
IPC: A61K8/96
Filed: 1993-10-22
Granted: 1997-03-06
Abstract: Cosmetic or dermopharmaceutic composition. This composition is characterised in that it contains, in a suitable vehicle, an antioxidising system of synergistic action consisting of the combination of a lysine, histidine or arginine lauroylmethionate and of at least one polyphenol chosen from:   a) a derivative of 2,5-dihydroxyphenylcarboxylic acid, a homologue or a corresponding salt,   b) an ester or amide of caffeic acid,   c) a flavonoid or an extract based on flavonoids, d) an extract of rosemary containing diphenols, and their mixtures.     The use of the antioxidising system allows good conservation for the compositions containing fatty substances which are sensitive to oxidation.
Patent DE-69304628-T2 (DE)
Inventor: BARJOLLE JEAN-PIERRE
IPC: B61D23/02
Filed: 1993-07-07
Granted: 1997-01-23
Abstract: The invention relates to a device facilitating access to a rail vehicle, comprising a plate (1) which can be moved between a retracted position, in which it is accommodated under the upper surface (6) of the floor (7) of the vehicle, and a deployed position, in which it forms an access board between the threshold (5) of the vehicle and a platform (2), the device comprising means for moving the plate and means for stopping the plate in its translational movement in the deployed position, characterised in that the means for moving the plate are arranged in the plane of the said plate, the device comprising means for tilting the plate about the translational stop means in such a way that the outer end of the plate rests on the platform and the plate presents, together with the threshold, a continuous surface without any staggering, the threshold remaining fixed. <IMAGE>
Patent DE-69312731-T2 (DE)
Inventor: SAIRANEN MARTTI
IPC: H01H9/54
Filed: 1993-11-30
Granted: 1997-12-04
Abstract: The present invention relates to a method of controlling an electronic switch and an electronic switch for carrying out the method. The electronic switch comprises an electromagnetic relay (1) and a controllable bidirectional semi-conductor switch (2), such as a triac, connected parallel with the switch (1b) of the relay and a control unit (3) for controlling the relay and the semi-conductor switch so that when connecting the load to a power source the semi-conductor switch is first turned on at the zero point of the AC voltage, subsequent to which and after a delay the switch of the relay is turned on, and when disconnecting the load from the power source, the switch of the relay is first turned off, subsequent to which and after a delay the semi-conductor switch is turned off at the zero point of the alternating current. According to the invention the control unit (3) also comprises means for turning off the semi-conductor switch (2) subsequent to turning on the switch (1b) of the relay (1) when connecting the load to a power source, and for turning on the semi-conductor switch (2) prior to turning off the switch (1b) of the relay (1) when disconnecting the load from the power source.
Patent DE-69320646-T2 (DE)
Inventor: SUNKARA SAI P
IPC: C07D473/02
Filed: 1993-03-15
Granted: 1999-01-14
Abstract: The present invention relates to a method of treating a patient suffering from a neoplastic disease state comprising administering to said patient an effective antineoplastic amount of a 2'-halomethylidene derivative in conjunctive therapy with an effective antineoplastic amount of a S phase or M-phase specific agent.
Patent DE-69330925-T2 (DE)
Inventor: SAWAYAMA IPPEI
IPC: H01L31/10
Filed: 1993-07-14
Granted: 2002-04-25
Abstract: A photovoltaic device of this invention has a semiconductor layer for generating a photovoltaic power and a collector electrode formed on the semiconductor layer to collect the power generated by the semiconductor layer. A conductive layer containing a conductive powder is formed on at least one side of the collector electrode closer to the semiconductor layer, and a metal layer is formed on the side away from the semiconductor layer. The metal layer covers the surface of the conductive layer away from the semiconductor layer. <IMAGE>
Patent DE-69332630-T2 (DE)
Inventor: BOWDON EDWARD K
IPC: H04Q3/52
Filed: 1993-05-10
Granted: 2003-07-03
Abstract: A method and system to immediately connect and reswitch connection configurations through a rearrangeable communications matrix that immediately connects an input gate causing rearrangeably blocked condition through the communications matrix to an output gate through a dedicated or extra switching element of the center. With the rearrangeably blocked condition, the method and system select a set of switching elements pairs from the center stage switches to form a plurality of possible connections from the input gates to the output gates that excludes the dedicated switching element. The method and system then determines from the possible connections a minimum rearrangement connection configuration that excludes the dedicated switch and that requires the minimum number of rearrangements of existing communications matrix connections. Then, the invention reswitches the matrix according to the minimum rearrangement connection configuration while maintaining all signal flow from the input gates to the output gates while removing connections through the dedicated switching element. The preferred embodiment has particular application for digital cross-connect networks that include a time domain and a space domain for connection configurations where rearrangeably blocked condition may occur in either domain. <IMAGE>   <IMAGE>
Patent DE-69333874-T2 (DE)
Inventor: LEWIS MICHAEL E
IPC: A61P9/10
Filed: 1993-07-26
Granted: 2006-05-04
Abstract: Derivatives of K-252a are useful for treating Parkinson's disease.
Patent DE-69420127-T2 (DE)
Inventor: BURGUET RODRIGO BLAS
IPC: A21C11/12
Filed: 1994-05-09
Granted: 2000-04-27
Abstract: The cutting device for effecting cuts on loaves transported in carriages comprises a prismatic frame (1) formed by pillars and cross-bars, defining as many levels as there are trays in the carriage. The device has knives (7) and an opening (4), along a diagonal plane, through which the carriage can come in and go out. The knives (7) adopt an operational position through the use of appropriate mechanisms in order to perform the simultaneous cuts on the loaves, in combination with the displacement of the carriage transporting said loaves. <IMAGE>   <IMAGE>
Patent DE-69421572-T2 (DE)
Inventor: MCCLURE DAVID CHARLES
IPC: G11C29/04
Filed: 1994-07-27
Granted: 2000-04-27
Abstract: Disclosed is an integrated circuit memory having a plurality of addressable elements and a plurality of redundant elements for substitution of the addressable elements. A configurable selection circuit for each redundant element allows for associating the redundant element with an address for access of the redundant element in place of an addressable element, upon permanent physical modification of the integrated circuit memory. Redundant element testing is provided by use of bypass circuitry, responsive to a redundant element test signal. The bypass circuitry includes circuitry associated with each redundant element, for simulating access of the redundant element without modification of the configurable selection circuit for the redundant element. Each redundant element has an address, unique among the redundant elements but duplicating an address for a regular element, which is used for accessing the redundant element during testing. <IMAGE>
Patent DE-69427120-T2 (DE)
Inventor: ANDERSON DAVID JOHN
IPC: A61K31/4433
Filed: 1994-02-03
Granted: 2001-08-23
Abstract: PCT No. PCT/US94/00938 Sec. 371 Date Aug. 4, 1995 Sec. 102(e) Date Aug. 4, 1995 PCT Filed Feb. 3, 1994 PCT Pub. No. WO94/18188 PCT Pub. Date Aug. 18, 1994The present invention relates to compounds of formula I which are 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl[b]pyran-2-ones useful for inhibiting a retrovirus in a mammalian cell infected with said retrovirus.    <IMAGE>  I  Wherein R10 and R20 taken together are:    <IMAGE>  II   <IMAGE>  III
Patent DE-69502490-T2 (DE)
Inventor: LARCHER PATRICK
IPC: H02B1/04
Filed: 1995-07-19
Granted: 1998-09-10
Abstract: The lateral connector has a moulded plug (30) carrying the contacts. The plug slides into a hole in the wall of the electrical module. A screw locks the plug into the wall once it is in place. The plug and the hole have a profile that ensures the plug is rigidly located in the module wall. The plug has a bent tongue (40) that is accessible from the outside of the module. The contact passes across the block, and is accessible (42) at the bottom of a valley formed in the block. A fixed contact in the wall of the module engages the exposed part of the contact when the plug is in place. Two plastic tongues (34) project beneath the block, and are engaged by the fixing screw when the plug is in place.
Patent DE-69502744-T2 (DE)
Inventor: WASSERMAN ERIC PAUL
IPC: C08F210/16
Filed: 1995-02-16
Granted: 1998-10-01
Abstract: Metallocene-containing catalyst compositions that include inert filler, a method for their preparation, and a method for their use in production of polyolefins are disclosed and claimed. The catalyst compositions contain solid particles of a mixture comprising a) a metallocene catalyst; b) a cocatalyst capable of activating said metallocene catalyst; and c) particulate filler material having an average particle size of less than about 10 micrometers that is unreactive with the metallocene catalyst and the cocatalyst. They are prepared by spray drying a slurry of the constituents.
Patent DE-69512976-T2 (DE)
Inventor: OGNIER JEAN-FRANCOIS
IPC: A61B17/00
Filed: 1995-02-23
Granted: 2000-05-18
Abstract: PCT No. PCT/FR95/00218 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Feb. 23, 1993 PCT Pub. No. WO95/23006 PCT Pub. Date Aug. 31, 1995A medical insufflator has a flexible tube having a downstream end provided with a needle and an upstream end, the tube and needle forming an insufflation flow path for a neutral gas into a surgical cavity into which the needle is inserted, a supply of the neutral gas under pressure connected to the upstream end, and a flow-control valve along the flow path at the upstream end. It is operated by measuring an insufflation pressure at the upstream end of the insufflation path, continuously calculating intracavity pressure from the insufflation pressure by evaluating loss of pressure of the flow path, comparing the calculated intracavity pressure and a preset value of this intracavity pressure, and controlling the flow-control valve as a function of the result of the comparison with the above-mentioned preset value in order to continuously supply a flow of the neutral gas that is minimally sufficient to compensate for leakage of gas from the surgical cavity and to maintain the intracavity pressure generally equal to the preset value.
Patent DE-69513697-T2 (DE)
Inventor: PALLEGGI GUIDO
IPC: B66F9/24
Filed: 1995-01-05
Granted: 2000-06-21
Abstract: A lift truck (10) has a tractive-power electric motor (16), an electric motor which actuates a pump for the hydraulic circuits, and batteries (19) which supply the electric motors. In order to obtain a long working life as well as reliability and a high performance, the tractive-power motor (16) or both motors are asynchronous and there are provided devices (30) for sensing the angular positions and angular velocities of the motors and an electronic control unit (52) connected to the sensor devices (30) for controlling the power supplies to the motors in dependence on required velocities for the motors and on the basis of data provided by the sensor devices. <IMAGE>
Patent DE-69514655-T2 (DE)
Inventor: CLUNGEON NANCY S
IPC: C08G69/48
Filed: 1995-03-28
Granted: 2000-09-07
Abstract: Wet-strength resins and methods of making the same by reacting a polyamine, polyaminoamide or alkylated derivative thereof with a cross-linking agent selected from diepoxides, piperazine dichlorohydrin, methylene bis-acrylamide, chloroacetyl chloride and maleic anhydride.
Patent DE-69515702-T2 (DE)
Inventor: BECKETT RAYMOND PAUL
IPC: A61K31/495
Filed: 1995-01-20
Granted: 2000-08-10
Abstract: The novel compound L-tert-leucine-2-pyridylamide is a useful intermediat for the preparation of matrix metalloproteinase inhibitor compounds.
Patent DE-69525049-T2 (DE)
Inventor: PETERZELL E
IPC: H03G3/20
Filed: 1995-04-28
Granted: 2002-08-29
Abstract: An automatic gain control (AGC) apparatus for a digital receiver is disclosed herein. The AGC apparatus includes an adjustable gain amplifier having an input port for receiving an input signal, a control port for receiving a gain control signal, and an output port for providing an output signal. The AGC apparatus further includes a measurement circuit for generating a received power signal based on the power of the output signal. A saturating integrator compares the received power signal to a reference signal and generates an gain control signal in response to a result of the comparison. The saturating integrator includes a decision circuit for enabling integration based on values of the received power signal, the reference signal, and the gain control signal. In a preferred implementation the utilization of an input limiter in conjunction with an analog to digital converter enables accommodation of an increased input signal dynamic range. Accordingly, the AGC apparatus is capable of being used in digital demodulation of FM signals. The AGC apparatus may also be employed within a dual mode receiver designed to process both FM and code division multiple access (CDMA) input signals.
Patent DE-69527302-T2 (DE)
Inventor: TUULOS MARTTI
IPC: H04M3/56
Filed: 1995-02-15
Granted: 2002-11-21
Abstract: PCT No. PCT/FI95/00071 Sec. 371 Date Dec. 27, 1995 Sec. 102(e) Date Dec. 27, 1995 PCT Filed Feb. 15, 1995 PCT Pub. No. WO95/23475 PCT Pub. Date Aug. 31, 1995A method and telecommunication system for controlling a call in a telecommunication system, which comprises a telecommunication network and a first subscriber station and one or more other subscriber stations, in which method is maintained a call in which the subscriber stations participate. In the method of the invention, to remove the desired subscriber stations from the call, the first subscriber station instructs the telecommunication network to remove one or more other subscriber stations from the call, and the telecommunication network removes one or more other subscriber stations from the call without the call being interrupted. In particular, upon issuance of an addition message containing subscriber IDs, the system adds any identified subscriber not yet participating in the call and removes any identified subscriber already participating in the call.